LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.43 | 84.90 | 2001 | 3459 | 0.5784 | 0.8054 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.43 | 84.90 | 2120 | 3459 | 0.6128 | 0.8250 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.43 | 84.90 | 2187 | 3459 | 0.6322 | 0.8357 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.14 | 84.90 | 187 | 3682 | 0.0508 | 0.1563 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.14 | 84.90 | 2109 | 3682 | 0.5728 | 0.8052 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.14 | 84.90 | 2244 | 3682 | 0.6094 | 0.8259 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.14 | 84.90 | 2315 | 3682 | 0.6287 | 0.8364 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.84 | 84.90 | 214 | 4003 | 0.0535 | 0.1809 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.84 | 84.90 | 2200 | 4003 | 0.5496 | 0.7958 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.84 | 84.90 | 2348 | 4003 | 0.5865 | 0.8170 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.84 | 84.90 | 2437 | 4003 | 0.6088 | 0.8292 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.55 | 84.90 | 220 | 4287 | 0.0513 | 0.1833 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.55 | 84.90 | 2305 | 4287 | 0.5376 | 0.7922 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.55 | 84.90 | 2504 | 4287 | 0.5840 | 0.8186 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.55 | 84.90 | 2567 | 4287 | 0.5987 | 0.8266 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.25 | 84.90 | 265 | 4539 | 0.0584 | 0.2193 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.25 | 84.90 | 2426 | 4539 | 0.5344 | 0.7932 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.25 | 84.90 | 2639 | 4539 | 0.5813 | 0.8197 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.25 | 84.90 | 2701 | 4539 | 0.5950 | 0.8270 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.95 | 84.90 | 300 | 4952 | 0.0606 | 0.2401 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.95 | 84.90 | 2544 | 4952 | 0.5137 | 0.7853 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.95 | 84.90 | 2775 | 4952 | 0.5603 | 0.8120 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.95 | 84.90 | 2838 | 4952 | 0.5730 | 0.8189 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 48.65 | 84.90 | 315 | 5328 | 0.0591 | 0.2455 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 48.65 | 84.90 | 2639 | 5328 | 0.4952 | 0.7780 | MN20160318_Q02 | K22 |